Extracellular vesicles (EVs) have gained increasing attention in recent years as a valuable focus of scientific investigation, owing to their potential therapeutic properties and wide-ranging uses in medicine. EVs are a heterogeneous population of membrane-enclosed vesicles with lipid bilayers, released by cells from both animal and plant origins. These widespread vesicles play a crucial role in cell-to-cell communication and serve as carriers for a variety of biomolecules such as proteins, lipids, and nucleic acids. The most common method of classifying EVs is based on their biogenesis pathway, distinguishing exosomes, microvesicles, and apoptotic bodies as the major types. In recent years, there has been a growing interest in PDEs, as they offer a practical and eco-friendly alternative to exosomes sourced from mammals. Mounting data from both laboratory-based and animal model experiments indicate that PDEs have natural therapeutic properties that modulate biological activities within cells, demonstrating properties such as anti-inflammatory, antioxidant, and anticancer effects that may aid in treating diseases and enhancing human well-being. Moreover, PDEs hold promise as reliable and biologically compatible carriers for drug delivery. Although studies conducted before clinical trials have yielded encouraging results, numerous unresolved issues and gaps in understanding remain, which must be resolved to facilitate the effective advancement of PDEs toward medical use in human patients. A key concern is the absence of unified procedures for processing materials and for obtaining PDEs from different botanical sources. This article provides a comprehensive summary of existing findings on PDEs, critically examining the hurdles they face, and highlighting their substantial promise as a novel class of therapeutic tools for a range of illnesses.

The One Health paradigm—recognizing the interconnected health of humans, animals, and the environment—promotes the development of sustainable technologies that enhance human health while minimizing ecological impact. In this context, bio-based hydrogels have emerged as a promising class of biomaterials for advanced medical applications. Produced through biotechnological methods such as genetic engineering and microbial fermentation, these hydrogels are composed of renewable and biocompatible materials, including recombinant collagen, elastin, silk fibroin, bacterial cellulose, xanthan gum, and hyaluronic acid. Their high water content, structural tunability, and biodegradability make them ideal candidates for various biomedical applications such as wound healing, tissue regeneration, and the design of extracellular matrix (ECM)-mimicking scaffolds. By offering controlled mechanical properties, biocompatibility, and the potential for minimally invasive administration, sustainable hydrogels represent a strategic innovation for regenerative medicine and therapeutic interventions. This review discusses the characteristics and medical applications of these hydrogels, highlighting their role in advancing sustainable healthcare solutions within the One Health framework.

Micro- and nanoplastics (MNPs) are increasingly recognized as pervasive environmental contaminants with profound implications for ecosystems and human health. Their small size, compositional diversity, and occurrence across complex matrices—including water, soil, food, and biological samples—pose substantial analytical challenges. Conventional techniques such as vibrational spectroscopy, chromatographic analysis, and electron microscopy have yielded critical insights into MNP composition, morphology, and distribution; however, these methods often face limitations in sensitivity, throughput, and adaptability to real-world samples. Recent advances in nanotechnology have catalyzed the emergence of nanodevices—encompassing nanosensors, nanopore systems, integrated lab-on-a-chip platforms and nanostructured capture materials—that promise enhanced sensitivity, specificity, and the capacity for real-time, in situ detection. These innovations not only facilitate high-throughput analysis but also provide novel opportunities for integrated characterization of MNPs across diverse matrices. This review synthesizes the current state of nanodevice-based MNP detection, critically examining their principles, performance, and limitations relative to conventional approaches, and outlining the key needs for standardization, matrix-specific adaptation, and regulatory harmonization.

Botanical extracts represent a rich and sustainable source of polyphenolic compounds with significant potential in anticancer research. Among these, hesperidin, naringenin, hydroxytyrosol, oleuropein, and quercetin have attracted considerable attention due to their abundance in widely consumed plants such as citrus fruits, olive derivatives, and various fruits and vegetables. However, their clinical translation is hindered by intrinsic limitations including poor solubility, low stability, and limited bioavailability. In this context, nanotechnology-based drug delivery systems have emerged as a promising strategy to enhance the therapeutic performance of these bioactive compounds. This review provides an overview of polyphenol-rich botanical matrices and focuses on recent advances in their nanoformulation. Various nanocarriers, including polymeric nanoparticles, liposomes, solid lipid nanoparticles, and nanoemulsions, are discussed in terms of their ability to improve physicochemical properties, protect against degradation, and enhance delivery efficiency. Special attention is given to the challenges associated with the encapsulation of complex botanical extracts and the need to preserve their compositional integrity and synergistic effects. Overall, nanoformulation represents a powerful approach to overcome current limitations and unlock the full potential of plant-derived polyphenols in anticancer applications.

Carbohydrate-based hydrogels represent a new advancement in the development of multifunctional biomedical systems, thanks to their intrinsic biocompatibility, structural versatility, and capacity for functional modification. This review examines the latest progress made in employing these materials as intelligent theranostic platforms, with a particular focus on their role as biosensors and therapeutic drug delivery devices. Engineered to interact dynamically with the biological environment, carbohydrate hydrogels enable the site-specific release of therapeutic agents while simultaneously supporting the monitoring of key physiological markers. Their dual functionality offers significant advantages in managing complex pathologies such as cancer, metabolic disorders, and chronic inflammation, where personalized treatment and real-time feedback are essential. By exploring their biological application, this review underscores the pivotal role played by carbohydrate hydrogels in advanced therapeutic technologies.

The increasing global burden of cancer, together with the need for more sustainable resource management, has stimulated growing interest in the valorization of agro-industrial plant residues as sources of bioactive compounds with therapeutic potential. This review highlights the potential of plant by-products—including citrus peels, olive leaves, date palm residues, and tea and coffee processing wastes—as sustainable reservoirs of polyphenols and other phytochemicals with significant anticancer activity. Key compounds such as hesperidin and naringenin from citrus peels, oleuropein and hydroxytyrosol from olive leaves, quercetin and syringic acid from date palm residues, and chlorogenic acid and epigallocatechin gallate from tea and coffee by-products have demonstrated promising antitumor effects in both in vitro and in vivo studies. These molecules exert their activity through multiple mechanisms, including the inhibition of cancer cell proliferation, induction of apoptosis, regulation of the cell cycle, and modulation of major oncogenic signaling pathways such as PI3K/AKT, MAPK, NF-κB, and EGFR. For instance, hydroxytyrosol induces apoptosis and cell cycle arrest while inhibiting the PI3K/AKT and MAPK pathways. Quercetin limits metastasis and glycolysis and suppresses VEGF, PKM2, and AKT signaling. Ferulic acid suppresses tumor growth by inhibiting the PI3K/AKT and JAK2/STAT6 pathways, thereby promoting apoptosis (in vitro and in vivo). In addition to their pharmacological potential, the recovery of these compounds from plant waste supports circular economy strategies by reducing environmental impact and promoting the development of value-added products. Future research should focus on optimizing extraction methods, improving bioavailability and stability, and validating safety and efficacy through well-designed preclinical and clinical studies.